Ning Ma

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Ann‐Lii Cheng, Shukui Qin, Masafumi Ikeda et al. · Journal of Hepatology · 2021 · 1.6K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation

Yi-Han Chen, Shi-Jie Xu, Saı̈d Bendahhou et al. · Science · 2003 · 1K citations

Medicine, Cardiology, Genetics +17

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients

Bao‐Dong Qin, Ning Ma, Qingqin Tang et al. · Modern Rheumatology · 2015 · 450 citations

Life Sciences, Hematology, Immunology +17

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

Yiqing Yang, Min Xia, Qingfeng Jin et al. · The American Journal of Human Genetics · 2004 · 390 citations · Full text

Medicine, Cardiology, Genetics +13